1-20 of 22
David L. Bartlett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neutrophil Extracellular Traps Drive Mitochondrial Homeostasis in Tumors to Augment Growth

Hamza O. Yazdani, Eva Roy, Alexander J. Comerci, Dirk J. van der Windt, Hongji Zhang, Hai Huang, Patricia Loughran, Sruti Shiva, David A. Geller, David L. Bartlett, Allan Tsung, Tai Sheng, Richard L. Simmons, Samer Tohme
Journal: Cancer Research
Cancer Res (2019) 79 (21): 5626–5639.
https://doi.org/10.1158/0008-5472.CAN-19-0800
Published: 01 November 2019
View articletitled, Neutrophil Extracellular Traps Drive Mitochondrial Homeostasis in Tumors to Augment Growth
Open the PDF for Neutrophil Extracellular Traps Drive Mitochondrial Homeostasis in Tumors to Augment Growth in another window
Includes: Supplementary data
Journal Articles

Abstract 2264: Synergistic combination of oncolytic virotherapy and immunotherapy for glioma

Bingtao Tang, Zong Sheng Guo, David L. Bartlett, David Yan, Claire P. Schane, Jia Liu, Grant McFadden, Joanna L. Shisler, Edward J. Roy
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2264.
https://doi.org/10.1158/1538-7445.AM2019-2264
Published: 01 July 2019
View articletitled, Abstract 2264: Synergistic combination of oncolytic virotherapy and immunotherapy for glioma
Journal Articles

Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment

Marie-Nicole Theodoraki, Saigopalakrishna Yerneni, Saumendra N. Sarkar, Brian Orr, Ravikumar Muthuswamy, Jamie Voyten, Francesmary Modugno, Weijian Jiang, Melissa Grimm, Per H. Basse, David L. Bartlett, Robert P. Edwards, Pawel Kalinski
Journal: Cancer Research
Cancer Res (2018) 78 (15): 4292–4302.
https://doi.org/10.1158/0008-5472.CAN-17-3985
Published: 31 July 2018
View articletitled, Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
Open the PDF for Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment in another window
Includes: Supplementary data
Journal Articles

Abstract 2321: Molecular crosstalk between ferroptosis and apoptosis: Emerging role of ER stress-induced p53-independent PUMA expression

Young-Sun Lee, Se Hoon Hong, Dae-Hee Lee, Min J. Jo, Yoo A. Jeong, William T. Kwon, Haroon A. Choudry, David L. Bartlett, Yong J. Lee
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2321.
https://doi.org/10.1158/1538-7445.AM2018-2321
Published: 01 July 2018
View articletitled, Abstract 2321: Molecular crosstalk between ferroptosis and apoptosis: Emerging role of ER stress-induced p53-independent PUMA expression
Journal Articles

Abstract 3009: Targeting G-protein coupled receptor-related pathway in mucinous tumors

Ashok K. Dilly, Yong J. Lee, Herbert J. Zeh, David L. Bartlett, Mohammad Haroon A. Choudry.
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3009.
https://doi.org/10.1158/1538-7445.AM2016-3009
Published: 15 July 2016
View articletitled, Abstract 3009: Targeting G-protein coupled receptor-related pathway in mucinous tumors
Journal Articles

NF-κB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells

Ravikumar Muthuswamy, Erik Berk, Beth Fallert Junecko, Herbert J. Zeh, Amer H. Zureikat, Daniel Normolle, The Minh Luong, Todd A. Reinhart, David L. Bartlett, Pawel Kalinski
Journal: Cancer Research
Cancer Res (2012) 72 (15): 3735–3743.
https://doi.org/10.1158/0008-5472.CAN-11-4136
Published: 31 July 2012
View articletitled, NF-κB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells
Open the PDF for NF-κB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells in another window
Includes: Supplementary data
Journal Articles

Abstract 1544: Combined oncolytic virotherapy and immunotherapy for malignant mesothelioma

Z. Sheng Guo, Jingjiao Zhou, Mark E. O'Malley, Magesh Sathaiah, David L. Bartlett
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1544.
https://doi.org/10.1158/1538-7445.AM2012-1544
Published: 15 April 2012
View articletitled, Abstract 1544: Combined oncolytic virotherapy and immunotherapy for malignant mesothelioma
Journal Articles

Abstract 5253: MEK-ERK pathway inhibition reduces mucin production in a murine xenograft model of pseudomyxoma peritonei

Haroon A. Choudry, Arun Mavanur, Mark E. O'Malley, Zong Sheng Guo, Herbert J. Zeh, David L. Bartlett
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 5253.
https://doi.org/10.1158/1538-7445.AM2012-5253
Published: 15 April 2012
View articletitled, Abstract 5253: MEK-ERK pathway inhibition reduces mucin production in a murine xenograft model of pseudomyxoma peritonei
Journal Articles

Oncolytic Virus and Anti–4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer

Liza B. John, Linda J. Howland, Jacqueline K. Flynn, Alison C. West, Christel Devaud, Connie P. Duong, Trina J. Stewart, Jenny A. Westwood, Z. Sheng Guo, David L. Bartlett, Mark J. Smyth, Michael H. Kershaw, Phillip K. Darcy
Journal: Cancer Research
Cancer Res (2012) 72 (7): 1651–1660.
https://doi.org/10.1158/0008-5472.CAN-11-2788
Published: 01 April 2012
View articletitled, Oncolytic Virus and Anti–4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer
Open the PDF for Oncolytic Virus and Anti–4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 1498: The combination of immunosuppression and carrier cells significantly enhances poxvirus delivery and the efficacy of its oncolytic virotherapy in the pre-immunized host

Zongsheng Guo, Prag Thirunavukkarasu, Vamsi Parimi, Mark E. O'Malley, Frances Austin, Magesh Sathaiah, David L. Bartlett
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1498.
https://doi.org/10.1158/1538-7445.AM10-1498
Published: 15 April 2010
View articletitled, Abstract 1498: The combination of immunosuppression and carrier cells significantly enhances poxvirus delivery and the efficacy of its oncolytic virotherapy in the pre-immunized host
Journal Articles

Abstract 4754: Type-1 dendritic cell vaccines in combination with poly-ICLC-association between positive tetramer response and 6-month progression-free survival in patients with recurrent malignant glioma

Hideho Okada, Frank S. Lieberman, Aki Hoji, Pawel Kalinski, Arlan H. Mintz, Johnathan A. Engh, Deric M. Park, David L. Bartlett, Herbert Zeh, Theresa L. Whiteside, Lisa H. Butterfield, Ronald L. Hamilton, Andres M. Salazar, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4754.
https://doi.org/10.1158/1538-7445.AM10-4754
Published: 15 April 2010
View articletitled, Abstract 4754: Type-1 dendritic cell vaccines in combination with poly-ICLC-association between positive tetramer response and 6-month progression-free survival in patients with recurrent malignant glioma
Journal Articles

Improved in vitro cytotoxicity of vaccinia virus in colon cancer cells by expression of murine tumor necrosis factor-related apoptosis-inducing ligand and combination with chemotherapy

Mohammed F. Ziauddin, Zongsheng Guo, Petar Popovic, Maihgan Kavanagh, Mark E. O'Malley, Yong Lee, David L. Bartlett
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 182.
Published: 15 April 2006
View articletitled, Improved in vitro cytotoxicity of vaccinia virus in colon cancer cells by expression of murine tumor necrosis factor-related apoptosis-inducing ligand and combination with chemotherapy
Journal Articles

The Enhanced Tumor Selectivity of an Oncolytic Vaccinia Lacking the Host Range and Antiapoptosis Genes SPI-1 and SPI-2

Z. Sheng Guo, Arpana Naik, Mark E. O'Malley, Petar Popovic, Richard Demarco, Yun Hu, Xiaoyu Yin, Shuting Yang, Herbert J. Zeh, Bernard Moss, Michael T. Lotze, David L. Bartlett
Journal: Cancer Research
Cancer Res (2005) 65 (21): 9991–9998.
https://doi.org/10.1158/0008-5472.CAN-05-1630
Published: 01 November 2005
View articletitled, The Enhanced Tumor Selectivity of an Oncolytic Vaccinia Lacking the Host Range and Antiapoptosis Genes SPI-1 and SPI-2
Open the PDF for The Enhanced Tumor Selectivity of an Oncolytic Vaccinia Lacking the Host Range and Antiapoptosis Genes SPI-1 and SPI-2 in another window
Journal Articles

HMGB1 as a marker of tumor development in mice with spontaneous hepatoma and implanted MC38 adenocarcinoma

Xiang Da Dong, Petar Popovic, Michael T. Lotze, Kevin Stavely-O’carroll, Sri Chalikonda, David L. Bartlett, Herbert J. Zeh III
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1109.
Published: 01 May 2005
View articletitled, HMGB1 as a marker of tumor development in mice with spontaneous hepatoma and implanted MC38 adenocarcinoma
Journal Articles

DNA demethylating agent 5-Aza-2’-Deoxycytidine up-regulates LIGHT gene expression in human pancreatic carcinoma

Xiao-Yu Yin, Mark E. O’Malley, Shuting Yang, David L. Bartlett, Zongsheng Guo
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 216.
Published: 01 May 2005
View articletitled, DNA demethylating agent 5-Aza-2’-Deoxycytidine up-regulates LIGHT gene expression in human pancreatic carcinoma
Journal Articles

Deletions of Three Anti-Apoptosis Viral Genes From Vaccinia Enhances Its Tumor Selectivity For Viral Oncolytic Therapy

Shuting Yang, Mark O’Malley, Zongsheng Guo, David L. Bartlett
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 794–795.
Published: 01 May 2005
View articletitled, Deletions of Three Anti-Apoptosis Viral Genes From Vaccinia Enhances Its Tumor Selectivity For Viral Oncolytic Therapy
Journal Articles

Serum SELDI-TOF-MS expression profiling and Luminex Xmap® marker panel classification analysis of pancreatic cancer patients and controls.

Herbert J. Zeh, III, David E. Malehorn, Jill M. Siegfried, David L. Bartlett, Michael T. Lotze, Stephen E. Winikoff, Anna Lokshin, William L. Bigbee
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 821–822.
Published: 01 April 2004
View articletitled, Serum SELDI-TOF-MS expression profiling and Luminex Xmap® marker panel classification analysis of pancreatic cancer patients and controls.
Journal Articles

vSPT, a triple–mutated vaccinia functions as an oncolytic virus with high tumor selectivity.

Shuting Yang, Z. Sheng Guo, Mark E. O’Malley, David L. Bartlett
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 540.
Published: 01 April 2004
View articletitled, vSPT, a triple–mutated vaccinia functions as an oncolytic virus with high tumor selectivity.
Journal Articles

Systemic Cancer Therapy with a Tumor-selective Vaccinia Virus Mutant Lacking Thymidine Kinase and Vaccinia Growth Factor Genes

J. Andrea McCart, Jerrold M. Ward, John Lee, Yun Hu, H. Richard Alexander, Steven K. Libutti, Bernard Moss, David L. Bartlett
Journal: Cancer Research
Cancer Res (2001) 61 (24): 8751–8757.
Published: 01 December 2001
View articletitled, Systemic Cancer Therapy with a Tumor-selective Vaccinia Virus Mutant Lacking Thymidine Kinase and Vaccinia Growth Factor Genes
Open the PDF for Systemic Cancer Therapy with a Tumor-selective Vaccinia Virus Mutant Lacking Thymidine Kinase and Vaccinia Growth Factor Genes in another window
Journal Articles

Antiangiogenic Gene Therapy of Cancer Utilizing a Recombinant Adenovirus to Elevate Systemic Endostatin Levels in Mice

Andrew L. Feldman, Nicholas P. Restifo, H. Richard Alexander, David L. Bartlett, Patrick Hwu, Prem Seth, Steven K. Libutti
Journal: Cancer Research
Cancer Res (2000) 60 (6): 1503–1506.
Published: 01 March 2000
View articletitled, Antiangiogenic Gene Therapy of Cancer Utilizing a Recombinant Adenovirus to Elevate Systemic Endostatin Levels in Mice
Open the PDF for Antiangiogenic Gene Therapy of Cancer Utilizing a Recombinant Adenovirus to Elevate Systemic Endostatin Levels in Mice in another window